Go Deep
HCW Biologics Inc.
HCW Biologics Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,009 | -0.1 | 0.37 | 0.88 | 116.50 |
| Oct 2026 | 23,006 | -0.1 | 0.37 | 0.88 | 117.45 |
| Oct 2026 | 20,609 | -0.1 | 0.37 | 0.88 | 116.62 |
| Oct 2026 | 20,630 | -0.1 | 0.35 | 0.88 | 110.94 |
| Oct 2026 | 20,624 | -0.1 | 0.35 | 0.88 | 109.72 |
| Oct 2026 | 20,638 | -0.1 | 0.34 | 0.88 | 105.72 |
HCW Biologics Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 135,568.0 | 6,543,001.0 | 27,010.0 | 15,606.0 |
| Net Profit | -5,219,231.0 | 3,472,480.0 | 719,232.0 | -4,554,336.0 |
| EPS | -11.6 | 1.4 | -6.1 | -12.1 |
HCW Biologics Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 54,232.0 | 2,566,792.0 | 2,841,794.0 | 6,722,090.0 | — |
| Net Profit | -7,959,709.0 | -30,023,814.0 | -24,994,277.0 | -14,900,703.0 | — |
| EPS | -63.8 | -184.8 | -168.0 | -100.8 | — |
HCW Biologics Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 24,520,013.0 | 30,236,578.0 | 28,513,660.0 | 46,809,155.0 | — |
| Total Liabilities | 21,755,244.0 | 37,006,750.0 | 15,051,943.0 | 9,380,649.0 | — |
| Total Equity | 2,764,769.0 | -6,770,172.0 | 13,461,717.0 | 37,428,506.0 | — |
Owes vs Owns
HCW Biologics Inc. owed $0.72 for every $1 it owned in Jun 2026, up from $0.20 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.72× | 0.89× | 1.22× | 0.53× | 0.20× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
HCW Biologics Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 8.0%Fixed assets (tangible) 85.2%Long-term investments 5.4%Other assets 1.3%
How it's funded — Dec 2025
Short-term debt 27.8%Payables 53.6%Other liabilities 7.4%Shareholders' equity 11.3%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 2.0 | 4.7 | 3.6 | 32.1 |
| Receivables | 0.0 | 0.6 | 1.5 | 0.4 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 20.9 | 22.9 | 20.5 | 10.8 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 1.3 | 1.6 | 1.6 | 1.6 |
| Other assets | 0.3 | 0.5 | 1.3 | 1.9 |
| Liabilities & equity | ||||
| Short-term debt | 6.8 | 6.3 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 7.4 | 6.3 | 6.4 |
| Payables | 13.1 | 22.3 | 6.2 | 1.2 |
| Other liabilities | 1.8 | 1.0 | 2.6 | 1.7 |
| Shareholders' equity | 2.8 | -6.8 | 13.5 | 37.4 |
| Net tangible assets | 2.8 | -6.8 | 13.5 | 37.4 |
HCW Biologics Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -13,391,617.0 | -14,227,428.0 | -22,514,121.0 | -10,386,110.0 | — |
| Investing Activities | 0.0 | -261,617.0 | 3,797,400.0 | 14,708,392.0 | — |
| Financing Activities | 10,669,509.0 | 15,568,516.0 | -14,534.0 | 6,273,397.0 | — |